Concepedia

Béatrice De Vos

BD

Statistics

Publications

17

Citations

3.5K

H-Index

17

Active since

2004

Affiliations

GlaxoSmithKline (Belgium)(Current)

GlaxoSmithKline (United Kingdom)

Cincinnati Children's Hospital Medical Center

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Tampere University

Béatrice De Vos is an author at GlaxoSmithKline (Belgium) specializing in viral vaccines, vaccinology, and infectious diseases.

Publications per year

2004–2023

17

Publications

17

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +17

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

Alexandre C. Linhares, F. Raúl Velázquez, Irene Pérez‐Schael et al. · The Lancet · 2008 · 379 citations

, , +17

Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants

Timo Vesikari, Aino Karvonen, Leena Puustinen et al. · The Pediatric Infectious Disease Journal · 2004 · 216 citations

, , +17

A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis

Béatrice De Vos, Timo Vesikari, Alexandre C. Linhares et al. · The Pediatric Infectious Disease Journal · 2004 · 168 citations · Full text

, , +17

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

Timo Vesikari, Aino Karvonen, Tiina Korhonen et al. · Vaccine · 2004 · 145 citations

, , +12

1–5 of 17